Estradiol - Bayer Schering Pharma
Alternative Names: Climarelle™; Estradiol oral - Bayer Schering Pharma; Estradiol transdermal - Bayer Schering Pharma; MenostarLatest Information Update: 26 Nov 2024
At a glance
- Originator Bayer HealthCare Pharmaceuticals; Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals; Bayer HealthCare Pharmaceuticals Inc.
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Postmenopausal osteoporosis
Most Recent Events
- 26 Nov 2024 No development reported - Phase-II/III for Postmenopausal osteoporosis (Prevention, In adults) in Czech Republic (PO)
- 26 Nov 2024 No development reported - Phase-II/III for Postmenopausal osteoporosis (Prevention, In adults) in Denmark (PO)
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)